Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...